IBDEI0A1 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12720,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12720,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,12720,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,12721,0)
 ;;=L23.7^^43^613^30
 ;;^UTILITY(U,$J,358.3,12721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12721,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,12721,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,12721,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,12722,0)
 ;;=L23.9^^43^613^31
 ;;^UTILITY(U,$J,358.3,12722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12722,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12722,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,12722,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,12723,0)
 ;;=L24.9^^43^613^163
 ;;^UTILITY(U,$J,358.3,12723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12723,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12723,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,12723,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,12724,0)
 ;;=L25.9^^43^613^115
 ;;^UTILITY(U,$J,358.3,12724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12724,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12724,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,12724,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,12725,0)
 ;;=L26.^^43^613^148
 ;;^UTILITY(U,$J,358.3,12725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12725,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,12725,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,12725,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,12726,0)
 ;;=L27.0^^43^613^265
 ;;^UTILITY(U,$J,358.3,12726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12726,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,12726,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,12726,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,12727,0)
 ;;=L27.1^^43^613^266
 ;;^UTILITY(U,$J,358.3,12727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12727,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,12727,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,12727,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,12728,0)
 ;;=L29.0^^43^613^250
 ;;^UTILITY(U,$J,358.3,12728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12728,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,12728,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,12728,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,12729,0)
 ;;=L29.9^^43^613^251
 ;;^UTILITY(U,$J,358.3,12729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12729,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,12729,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,12729,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,12730,0)
 ;;=L30.0^^43^613^232
 ;;^UTILITY(U,$J,358.3,12730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12730,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,12730,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,12730,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,12731,0)
 ;;=L30.1^^43^613^140
 ;;^UTILITY(U,$J,358.3,12731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12731,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,12731,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,12731,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,12732,0)
 ;;=L30.2^^43^613^132
 ;;^UTILITY(U,$J,358.3,12732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12732,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,12732,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,12732,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,12733,0)
 ;;=L30.4^^43^613^144
 ;;^UTILITY(U,$J,358.3,12733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12733,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,12733,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,12733,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,12734,0)
 ;;=L30.8^^43^613^135
 ;;^UTILITY(U,$J,358.3,12734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12734,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,12734,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,12734,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,12735,0)
 ;;=L30.9^^43^613^136
 ;;^UTILITY(U,$J,358.3,12735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12735,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12735,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,12735,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,12736,0)
 ;;=L40.0^^43^613^253
 ;;^UTILITY(U,$J,358.3,12736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12736,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,12736,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,12736,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,12737,0)
 ;;=L40.1^^43^613^256
 ;;^UTILITY(U,$J,358.3,12737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12737,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,12737,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,12737,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,12738,0)
 ;;=L40.2^^43^613^11
 ;;^UTILITY(U,$J,358.3,12738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12738,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,12738,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,12738,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,12739,0)
 ;;=L40.3^^43^613^255
 ;;^UTILITY(U,$J,358.3,12739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12739,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,12739,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,12739,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,12740,0)
 ;;=L40.4^^43^613^157
 ;;^UTILITY(U,$J,358.3,12740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12740,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,12740,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,12740,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,12741,0)
 ;;=L40.8^^43^613^252
 ;;^UTILITY(U,$J,358.3,12741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12741,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,12741,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,12741,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,12742,0)
 ;;=L40.9^^43^613^254
 ;;^UTILITY(U,$J,358.3,12742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12742,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,12742,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,12742,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,12743,0)
 ;;=L50.9^^43^613^286
 ;;^UTILITY(U,$J,358.3,12743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12743,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,12743,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,12743,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,12744,0)
 ;;=L53.8^^43^613^147
 ;;^UTILITY(U,$J,358.3,12744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12744,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,12744,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,12744,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,12745,0)
 ;;=L53.9^^43^613^146
 ;;^UTILITY(U,$J,358.3,12745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12745,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,12745,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,12745,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,12746,0)
 ;;=L54.^^43^613^145
 ;;^UTILITY(U,$J,358.3,12746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12746,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,12746,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,12746,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,12747,0)
 ;;=L56.0^^43^613^139
 ;;^UTILITY(U,$J,358.3,12747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12747,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,12747,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,12747,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,12748,0)
 ;;=L56.1^^43^613^138
 ;;^UTILITY(U,$J,358.3,12748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12748,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,12748,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,12748,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,12749,0)
 ;;=L56.2^^43^613^236
 ;;^UTILITY(U,$J,358.3,12749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12749,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,12749,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,12749,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,12750,0)
 ;;=L56.3^^43^613^268
 ;;^UTILITY(U,$J,358.3,12750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12750,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,12750,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,12750,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,12751,0)
 ;;=L57.0^^43^613^12
 ;;^UTILITY(U,$J,358.3,12751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12751,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,12751,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,12751,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,12752,0)
 ;;=L60.0^^43^613^161
 ;;^UTILITY(U,$J,358.3,12752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12752,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,12752,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,12752,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,12753,0)
 ;;=L60.1^^43^613^234
 ;;^UTILITY(U,$J,358.3,12753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12753,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,12753,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,12753,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,12754,0)
 ;;=L60.2^^43^613^233
 ;;^UTILITY(U,$J,358.3,12754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12754,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,12754,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,12754,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,12755,0)
 ;;=L60.3^^43^613^170
 ;;^UTILITY(U,$J,358.3,12755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12755,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,12755,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,12755,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,12756,0)
 ;;=L60.4^^43^613^88
 ;;^UTILITY(U,$J,358.3,12756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12756,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,12756,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,12756,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,12757,0)
 ;;=L60.5^^43^613^290
 ;;^UTILITY(U,$J,358.3,12757,1,0)
 ;;=^358.31IA^4^2
